Risako Miura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Risako Miura has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Atsushi Ikeda
Program of Applied Chemistry, Graduate School of Advanced Science and Engineering, Hiroshima University, 1-4-1 Kagamiyama, Higashi Hiroshima, 739-8527, Japan
4 shared publications - Riku Kawasaki
Program of Applied Chemistry, Graduate School of Advanced Science and Engineering, Hiroshima University, 1-4-1 Kagamiyama, Higashi Hiroshima, 739-8527, Japan
4 shared publications - Teruyuki Kondo
Department of Energy and Hydrocarbon Chemistry, Graduate School of Engineering, Kyoto University, Katsura, Nishikyo-ku, Kyoto 615-8510, Japan
4 shared publications - Yu Kimura
Department of Energy and Hydrocarbon Chemistry, Graduate School of Engineering, Kyoto University, Katsura, Nishikyo-ku, Kyoto 615-8510, Japan
4 shared publications - Kazunari Akiyoshi
Department of Immunology, Graduate School of Medicine
3 shared publications Keita Yamana
Applied Chemistry Program, Graduate School of Advanced Science and Engineering, Hiroshima University, 1-4-1 Kagamiyama, Higashi Hiroshima, 739-8527, Japan
3 shared publications
Latest Publications
- Open Access
- 8 September 2026
- Published by Springer Nature in Polymer Journal
- p. 1-8
Comparative study of mannose-containing polysaccharide nanogels for optimized M2 macrophage targeting and photoacoustic imaging
Immunotherapy efficacy is often hindered by the immunosuppressive “cold tumor” microenvironment, dominated by M2 macrophages. We developed pullulan–mannose–IR820 (PMI) nanogels as targeted photoacoustic (PA) contrast agents and performed a comparative study with mannan (MI) and fucoidan (FI) nanogels to establish structural design guidelines for M2 targeting. All the variants formed stable nanogels ( < 100 nm) driven by IR-820 self-association, providing robust PA signals. Despite the high intrinsic sugar content of natural polysaccharides, PMI nanogels exhibited significantly greater internalization by M2 macrophages. This superior efficiency was not due to electrostatic interactions, as all the variants possessed comparable negative ζ-potentials. Competitive inhibition assays revealed a moderate decrease in uptake ( ~ 10–15%) for all the nanogels, indicating that while nonspecific pathways are dominant in overall cell association, mannose receptors are partly involved. Remarkably, despite having a significantly lower mannose content than native mannan did, the inhibition rate of the PMI nanogel was comparable, suggesting that its unique pendant configuration offers superior spatial accessibility for efficient receptor interaction. Consequently, the PMI nanogels achieved the highest PA contrast in M2 macrophage imaging. These findings highlight that spatial ligand presentation, rather than absolute density, is a critical determinant in the design of next-generation drug delivery systems for targeting the immunosuppressive tumor microenvironment.
- 8 September 2026
- Published by Springer Nature in Polymer Journal
- p. 1-8
Open AccessComparative study of mannose-containing polysaccharide nanogels for optimized M2 macrophage targeting and photoacoustic imaging
Immunotherapy efficacy is often hindered by the immunosuppressive “cold tumor” microenvironment, dominated by M2 macrophages. We developed pullulan–mannose–IR820 (PMI) nanogels as targeted photoacoustic (PA) contrast agents and performed a comparative study with mannan (MI) and fucoidan (FI) nanogels to establish structural design guidelines for M2 targeting. All the variants formed stable nanogels ( < 100 nm) driven by IR-820 self-association, providing robust PA signals. Despite the high intrinsic sugar content of natural polysaccharides, PMI nanogels exhibited significantly greater internalization by M2 macrophages. This superior efficiency was not due to electrostatic interactions, as all the variants possessed comparable negative ζ-potentials. Competitive inhibition assays revealed a moderate decrease in uptake ( ~ 10–15%) for all the nanogels, indicating that while nonspecific pathways are dominant in overall cell association, mannose receptors are partly involved. Remarkably, despite having a significantly lower mannose content than native mannan did, the inhibition rate of the PMI nanogel was comparable, suggesting that its unique pendant configuration offers superior spatial accessibility for efficient receptor interaction. Consequently, the PMI nanogels achieved the highest PA contrast in M2 macrophage imaging. These findings highlight that spatial ligand presentation, rather than absolute density, is a critical determinant in the design of next-generation drug delivery systems for targeting the immunosuppressive tumor microenvironment.
- Open Access
- 8 September 2026
- Published by Royal Society of Chemistry (RSC) in RSC Mechanochemistry
- Vol. 3 (5) , 774-779
Mechanochemical preparation of a water-dispersible fluorescent boron-fused π-conjugated polymer–hyaluronic acid complex as a boron agent for boron neutron capture therapy
Preparation of water-dispersible nanocomplex of boron-fused π-conjugated polymer with hyaluronic acid.
- 8 September 2026
- Published by Royal Society of Chemistry (RSC) in RSC Mechanochemistry
- Vol. 3 (5) , 774-779
Open AccessMechanochemical preparation of a water-dispersible fluorescent boron-fused π-conjugated polymer–hyaluronic acid complex as a boron agent for boron neutron capture therapy
Preparation of water-dispersible nanocomplex of boron-fused π-conjugated polymer with hyaluronic acid.
- Open Access
- 21 August 2026
- Published by MDPI AG in Journal of Nanotheranostics
- Vol. 7 (3) , 20
Development and In Vitro Evaluation of Near-Infrared Dye-Conjugated Pullulan-Based Nanogels for M2 Macrophage-Targeted pH-Responsive Theranostic Agents
Immunotherapy can reduce treatment-related side effects but shows limited efficacy in “cold tumors,” whose immunosuppressive tumor immune microenvironment is characterized by abundant M2 macrophages and poor T cell infiltration. Because biopsy-based qualitative assessment of the tumor microenvironment is invasive and conventional imaging lacks functional information, this study aimed to develop an M2 macrophage-targeted theranostic agent enabling non-invasive photoacoustic (PA) imaging and pH-triggered cytotoxicity. A pullulan-based nanogel conjugated with mannose and near-infrared dye (IR-820) was further functionalized with the pH-responsive doxorubicin (DOX) prodrug, Aldoxorubicin, to develop Pullulan-mannose-IR820-Aldoxorubicin (PMID) nanogel. PMID was successfully synthesized, and the resulting self-assembled nanogels (<100 nm) exhibited a highly negative ζ-potential, near-infrared absorption peaks at 780 and 850 nm, and PA contrast comparable to IR-820 at 850 nm excitation. Dialysis studies demonstrated suppressed drug release at neutral pH (~20%) but accelerated release under acidic conditions, reaching ~80% within 48 h at pH 5.5, consistent with hydrazone hydrolysis and supporting tumor/lysosome-activated delivery. In RAW264.7 macrophages, PMID nanogel showed preferential uptake by M2-poralized versus M1-polarized macrophages, outperforming non-mannosylated PID nanogel and IR-820, and produced the strongest PA signal in M2 macrophage pellets. PMID nanogel also induced the highest concentration-dependent cytotoxicity in M2 macrophages, and microscopy indicated lysosomal accumulation of the nanogel with partial nuclear localization of released DOX. These findings support the use of PMID nanogel as M2 macrophage-targeted PA contrast agents and pH-responsive drug carriers with the potential to deplete immunosuppressive macrophages, modulate cold tumor microenvironments, and improve precision cancer theranostics.
- 21 August 2026
- Published by MDPI AG in Journal of Nanotheranostics
- Vol. 7 (3) , 20
Open AccessDevelopment and In Vitro Evaluation of Near-Infrared Dye-Conjugated Pullulan-Based Nanogels for M2 Macrophage-Targeted pH-Responsive Theranostic Agents
Immunotherapy can reduce treatment-related side effects but shows limited efficacy in “cold tumors,” whose immunosuppressive tumor immune microenvironment is characterized by abundant M2 macrophages and poor T cell infiltration. Because biopsy-based qualitative assessment of the tumor microenvironment is invasive and conventional imaging lacks functional information, this study aimed to develop an M2 macrophage-targeted theranostic agent enabling non-invasive photoacoustic (PA) imaging and pH-triggered cytotoxicity. A pullulan-based nanogel conjugated with mannose and near-infrared dye (IR-820) was further functionalized with the pH-responsive doxorubicin (DOX) prodrug, Aldoxorubicin, to develop Pullulan-mannose-IR820-Aldoxorubicin (PMID) nanogel. PMID was successfully synthesized, and the resulting self-assembled nanogels (<100 nm) exhibited a highly negative ζ-potential, near-infrared absorption peaks at 780 and 850 nm, and PA contrast comparable to IR-820 at 850 nm excitation. Dialysis studies demonstrated suppressed drug release at neutral pH (~20%) but accelerated release under acidic conditions, reaching ~80% within 48 h at pH 5.5, consistent with hydrazone hydrolysis and supporting tumor/lysosome-activated delivery. In RAW264.7 macrophages, PMID nanogel showed preferential uptake by M2-poralized versus M1-polarized macrophages, outperforming non-mannosylated PID nanogel and IR-820, and produced the strongest PA signal in M2 macrophage pellets. PMID nanogel also induced the highest concentration-dependent cytotoxicity in M2 macrophages, and microscopy indicated lysosomal accumulation of the nanogel with partial nuclear localization of released DOX. These findings support the use of PMID nanogel as M2 macrophage-targeted PA contrast agents and pH-responsive drug carriers with the potential to deplete immunosuppressive macrophages, modulate cold tumor microenvironments, and improve precision cancer theranostics.
- Open Access
- 17 March 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (17) , 15283-15289
Divergent synthesis of indenoisoquinolines and indenoisochromenes by rhodium-catalysed cyclocondensation of N -substituted benzamides with 2-diazoindenediones
Tuning the Cp*Rh catalyst system switches cyclocondensation outcomes: N -alkoxy/aryl benzamides furnish indenoisoquinolines, whereas N-tert -butyl benzamides selectively deliver indenoisochromenes, revealing steric control of the final cyclisation.
- 17 March 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (17) , 15283-15289
Open AccessDivergent synthesis of indenoisoquinolines and indenoisochromenes by rhodium-catalysed cyclocondensation of N -substituted benzamides with 2-diazoindenediones
Tuning the Cp*Rh catalyst system switches cyclocondensation outcomes: N -alkoxy/aryl benzamides furnish indenoisoquinolines, whereas N-tert -butyl benzamides selectively deliver indenoisochromenes, revealing steric control of the final cyclisation.
- Open Access
- 10 March 2026
- Published by MDPI AG in Nanomaterials
- Vol. 16 (6) , 343
Biocompatible Gadolinium Oxide Nanoparticles Incorporated Doxorubicin Enables Magnetic Resonance and Photoacoustic Dual Imaging for Cancer Theranostics
The engineering of theranostic nanoparticles, which integrate diagnostics and therapy in a single administration, enables targeted drug delivery and disease visualization. In cancer theranostics, gadolinium-based nanoparticles are valuable tools for noninvasive magnetic resonance imaging (MRI) and provide high-resolution images of the tumor. When MRI is combined with other imaging modalities, complementary therapeutic information is obtained for more accurate identification of tumor characteristics and precise guidance of anticancer drug delivery. Among the many possible modalities combined with MRI, photoacoustic imaging (PAI) is a candidate that enables sensitive in vivo detection of tumors. We have already succeeded in synthesizing biocompatible gelatin-coated gadolinium oxide nanoparticles with a controlled size by adjusting the timing of gelatin addition, which were a highly efficient contrast agent for MR and PA dual imaging. Herein, we conjugated a clinically used anticancer drug (doxorubicin, DOX) to size-defined and biocompatible gadolinium oxide nanoparticles which are novel theranostic probes. Succinylated gelatin enabled the electrostatic conjugation of DOX with gadolinium oxide nanoparticles, and the release of DOX was controlled through the enzymatic degradation of gelatin by matrix metalloproteinases-2 and -9 (MMP-2 and MMP-9), which are highly expressed in cancer cells. The released DOX efficiently inhibited the growth of HeLa cells in vitro and the growth of the inoculated tumor tissues in vivo. The dual-modality MRI and PAI capabilities provide anatomical information that assists in the localization and targeting of theranostic probes.
- 10 March 2026
- Published by MDPI AG in Nanomaterials
- Vol. 16 (6) , 343
Open AccessBiocompatible Gadolinium Oxide Nanoparticles Incorporated Doxorubicin Enables Magnetic Resonance and Photoacoustic Dual Imaging for Cancer Theranostics
The engineering of theranostic nanoparticles, which integrate diagnostics and therapy in a single administration, enables targeted drug delivery and disease visualization. In cancer theranostics, gadolinium-based nanoparticles are valuable tools for noninvasive magnetic resonance imaging (MRI) and provide high-resolution images of the tumor. When MRI is combined with other imaging modalities, complementary therapeutic information is obtained for more accurate identification of tumor characteristics and precise guidance of anticancer drug delivery. Among the many possible modalities combined with MRI, photoacoustic imaging (PAI) is a candidate that enables sensitive in vivo detection of tumors. We have already succeeded in synthesizing biocompatible gelatin-coated gadolinium oxide nanoparticles with a controlled size by adjusting the timing of gelatin addition, which were a highly efficient contrast agent for MR and PA dual imaging. Herein, we conjugated a clinically used anticancer drug (doxorubicin, DOX) to size-defined and biocompatible gadolinium oxide nanoparticles which are novel theranostic probes. Succinylated gelatin enabled the electrostatic conjugation of DOX with gadolinium oxide nanoparticles, and the release of DOX was controlled through the enzymatic degradation of gelatin by matrix metalloproteinases-2 and -9 (MMP-2 and MMP-9), which are highly expressed in cancer cells. The released DOX efficiently inhibited the growth of HeLa cells in vitro and the growth of the inoculated tumor tissues in vivo. The dual-modality MRI and PAI capabilities provide anatomical information that assists in the localization and targeting of theranostic probes.
- 16 September 2024
- Published by Wiley in Chemistry – An Asian Journal
- Vol. 19 (18)
Front Cover: Photoacoustic Imaging Using Polysaccharide‐Porphyrin Complexes by Photoirradiation at Long Wavelengths (Chem. Asian J. 18/2024)
- 16 September 2024
- Published by Wiley in Chemistry – An Asian Journal
- Vol. 19 (18)
Front Cover: Photoacoustic Imaging Using Polysaccharide‐Porphyrin Complexes by Photoirradiation at Long Wavelengths (Chem. Asian J. 18/2024)
- Open Access
- 4 July 2024
- Published by Wiley in Chemistry – An Asian Journal
- Vol. 19 (18) , e202400571
Photoacoustic Imaging Using Polysaccharide‐Porphyrin Complexes by Photoirradiation at Long Wavelengths
Photoacoustic (PA) imaging is a novel biological imaging technique with superior depth resolution compared to fluorescence imaging. The efficacy of PA imaging depends on contrast agents that possess considerable absorbance at longer wavelengths, coupled with high permeability in biological tissue and minimal fluorescence, achieved through mitigating aggregation‐caused quenching (ACQ) that attenuates PA intensity. Despite the successful transfer of porphyrin 2 featuring amino moieties from polysaccharides to liposomes, most of 2 incorporated within λ‐carrageenan (CGN‐2 complex) remained in CGN under acidic lysosomal conditions (pH 5.0). Consequently, the CGN‐2 complex exhibited a strong PA signal under 680 nm photoirradiation in Colon26 cells owing to the ACQ of 2. Moreover, the PA intensity of the CGN‐2 complex was further enhanced under 780 nm photoirradiation owing to the increased absorbance at 780 nm facilitated by the redshift of the Q‐band at pH 5.0.
- 4 July 2024
- Published by Wiley in Chemistry – An Asian Journal
- Vol. 19 (18) , e202400571
Open AccessPhotoacoustic Imaging Using Polysaccharide‐Porphyrin Complexes by Photoirradiation at Long Wavelengths
Photoacoustic (PA) imaging is a novel biological imaging technique with superior depth resolution compared to fluorescence imaging. The efficacy of PA imaging depends on contrast agents that possess considerable absorbance at longer wavelengths, coupled with high permeability in biological tissue and minimal fluorescence, achieved through mitigating aggregation‐caused quenching (ACQ) that attenuates PA intensity. Despite the successful transfer of porphyrin 2 featuring amino moieties from polysaccharides to liposomes, most of 2 incorporated within λ‐carrageenan (CGN‐2 complex) remained in CGN under acidic lysosomal conditions (pH 5.0). Consequently, the CGN‐2 complex exhibited a strong PA signal under 680 nm photoirradiation in Colon26 cells owing to the ACQ of 2. Moreover, the PA intensity of the CGN‐2 complex was further enhanced under 780 nm photoirradiation owing to the increased absorbance at 780 nm facilitated by the redshift of the Q‐band at pH 5.0.
- Open Access
- 23 April 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (9) , 4686
Theranostic Agent Combining Fullerene Nanocrystals and Gold Nanoparticles for Photoacoustic Imaging and Photothermal Therapy
Developing photoactivatable theranostic platforms with integrated functionalities of biocompatibility, targeting, imaging contrast, and therapy is a promising approach for cancer diagnosis and therapy. Here, we report a theranostic agent based on a hybrid nanoparticle comprising fullerene nanocrystals and gold nanoparticles (FGNPs) for photoacoustic imaging and photothermal therapy. Compared to gold nanoparticles and fullerene crystals, FGNPs exhibited stronger photoacoustic signals and photothermal heating characteristics by irradiating light with an optimal wavelength. Our studies demonstrated that FGNPs could kill cancer cells due to their photothermal heating characteristics in vitro. Moreover, FGNPs that are accumulated in tumor tissue via the enhanced permeation and retention effect can visualize tumor tissue due to their photoacoustic signal in tumor xenograft model mice. The theranostic agent with FGNPs shows promise for cancer therapy.
- 23 April 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (9) , 4686
Open AccessTheranostic Agent Combining Fullerene Nanocrystals and Gold Nanoparticles for Photoacoustic Imaging and Photothermal Therapy
Developing photoactivatable theranostic platforms with integrated functionalities of biocompatibility, targeting, imaging contrast, and therapy is a promising approach for cancer diagnosis and therapy. Here, we report a theranostic agent based on a hybrid nanoparticle comprising fullerene nanocrystals and gold nanoparticles (FGNPs) for photoacoustic imaging and photothermal therapy. Compared to gold nanoparticles and fullerene crystals, FGNPs exhibited stronger photoacoustic signals and photothermal heating characteristics by irradiating light with an optimal wavelength. Our studies demonstrated that FGNPs could kill cancer cells due to their photothermal heating characteristics in vitro. Moreover, FGNPs that are accumulated in tumor tissue via the enhanced permeation and retention effect can visualize tumor tissue due to their photoacoustic signal in tumor xenograft model mice. The theranostic agent with FGNPs shows promise for cancer therapy.
- Open Access
- 17 February 2022
- Published by Wiley in Small Methods
- Vol. 6 (2) , 2270015
Assessment of Surface Glycan Diversity on Extracellular Vesicles by Lectin Microarray and Glycoengineering Strategies for Drug Delivery Applications (Small Methods 2/2022)
- 17 February 2022
- Published by Wiley in Small Methods
- Vol. 6 (2) , 2270015
Open AccessAssessment of Surface Glycan Diversity on Extracellular Vesicles by Lectin Microarray and Glycoengineering Strategies for Drug Delivery Applications (Small Methods 2/2022)
- Open Access
- 25 February 2020
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 10 (14) , 8074-8079
Synergistic anti-tumor efficacy by combination therapy of a self-assembled nanogel vaccine with an immune checkpoint anti-PD-1 antibody
Combination therapy of OVA/CHP nanogel vaccine with anti-PD-1 antibody synergistically improved anti-tumor effect and survival rate without side effects.
- 25 February 2020
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 10 (14) , 8074-8079
Open AccessSynergistic anti-tumor efficacy by combination therapy of a self-assembled nanogel vaccine with an immune checkpoint anti-PD-1 antibody
Combination therapy of OVA/CHP nanogel vaccine with anti-PD-1 antibody synergistically improved anti-tumor effect and survival rate without side effects.